A potential new class of drugs may cut your risk of heart attack and stroke in an ingenious way: by targeting specific microbes in the gut. Learn how these new drugs can potentially lower two major risk factors for cardiovascular disease by lowering levels of a harmful compound called TMAO (trimethylamine N-oxide).
When most people think of their risk for having a heart attack or stroke, factors like cholesterol and blood pressure come to mind. But a new study shows that what’s in your gut can play a role as well.
Cleveland Clinic asked more than 100 of its top experts about the innovations set to reshape healthcare in the coming year. These are their answers — the Top 10 Innovations for 2014. There is a global hunt in progress using cardiovascular fingerprints — scientists call them biomarkers — to identify the risk of heart disease. … Read More